List of Tables
Table 1: Emerging Pharmaceutical Market: Brazil, Revenue, $bn, 2004–2011
Table 2: Emerging Pharmaceutical Market: Brazil, Revenue Forecasts, $bn, 2011–2018
Table 3: Emerging Pharmaceutical Market: Brazil, Population Age Structure, (%) ,1950–2050
Table 4: Emerging Pharmaceutical Market in Brazil, Population Forecast of Brazil, (Million), 2005–2050
Table 5: Emerging Pharmaceutical Market: Brazil, Number of Deaths by Major Diseases, (%), 2008
Table 6: Emerging Pharmaceutical Market: Brazil, Population Forecast for HIV/AIDS Prevalence (‘000), 2011-2018
Table 7: Emerging Pharmaceutical Market: Brazil, Population Forecast for CVD Prevalence (Million), 2011–2018
Table 8: Emerging Pharmaceutical Market: Brazil, Population Forecast for Diabetes Prevalence (Million), 2011-2018
Table 9: Emerging Pharmaceutical Market: Brazil, Population Forecast for Cancer Prevalence (‘000), 2011–2018
Table 10: Emerging Pharmaceutical Market: Brazil, GDP Results at Market Prices from 1Q-2010 to 1Q- 2011
Table 11: Emerging Pharmaceutical Market: Brazil, Per Capita Income, ($), 2000–2011
Table 12: Emerging Pharmaceutical Market: Brazil, Comparative Analysis of Healthcare Expenditure Ratios, Argentina, Mexico and BRIC Countries (%), 2010
Table 13: Emerging Pharmaceutical Market: Brazil, Public and Private Distribution, (%), 2008
Table 14: Emerging Pharmaceutical Market: Brazil, Healthcare Infrastructure, 2008
Table 15: Emerging Pharmaceutical Market – Brazil, Documents Required for Product Registration by ANVISA
Table 16: Emerging Pharmaceutical Market – Brazil, Clinical Trials Market, ($m), 2011–2018
Table 17: Emerging Pharmaceutical Market – Brazil, Number of Plan Members and Revenue, ($bn), 2011
Table 18: Emerging Pharmaceutical Market – Brazil, Private Healthcare Coverage Providers, Number of Plan Members and Revenue, (R $m), 2011
Table 19: Emerging Pharmaceutical Market – Brazil, Surgeries, Cost Comparison, the US and Brazil ($), 2009
Table 20: Emerging Pharmaceutical Market – Brazil, Recent M&A Deals, 2009–2011
Table 21: Emerging Pharmaceutical Market – Brazil, Recent Co-development Deals, 2011
Table 22: Emerging Pharmaceutical Market – Brazil, Recent Licensing Agreements, 2011